There has been a boom in startups that construct AI medical assistants, and medical scribes - which help doctors save time taken for note-taking and populating medical records - over the past year. Incumbents want their slice of the pie too.

Video-conferencing company Zoom yesterday said it is teaming up with one such AI medical scribe provider, Suki, to provide doctors on its platform with an AI scribe that can take notes on their consultation with patients. As high as 36% of all telehealth visits in the U.S. utilize Zoom, which makes it the most popular video-conferencing platform, according to industry intelligence group Definitive Healthcare.

Punit Soni, the founder and CEO of Suki, tells TechCrunch that Zoom has looked at every other AI medical scribe start-up as part of its consideration process. The startup has just closed a $70 million Series D deal earlier this month.

According to reports, Eric Yuan, the founder and CEO of Zoom, told Fortune earlier this month that the company plans to morph from a conferencing company to one that centers on AI tools for workplaces.

Amazon-owned One Medical has also mentioned that it is adding AI tools to assist clinicians using its platform and is saving them time on administrative tasks. It is not partnering with a startup in this space but harnesses Amazon's Bedrock for building AI applications and AWS HealthScribe, Amazon's home-grown note-taking platform for clinicians.

Large health systems and smaller doctors' offices have found that AI software can save them hours of time spent keeping up with necessary documentation. Most of those companies have also seen their revenues tick up quickly, investors say.

Other AI-based medical note-taking startups include Abridge, reportedly raising $250 million at a $2.5 billion valuation, Nabla, and Ambiance Healthcare. Microsoft's Nuance is also important in the market.

Despite the dramatic spread of the market, and perhaps a risk that foundational models could eventually supplant AI medical scribe startups by generalizing their capabilities, investors say the competition is distinct enough for now. The Abridge, for example, caters to large medical systems, while others are configured towards smaller medical offices.